We are live on
!
Find out more
BIP
Brandes Investment Partners Portfolio holdings
AUM
$14.1B
1-Year Est. Return
25.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+25.52%
3 Year Est. Return
+82.74%
5 Year Est. Return
+120.97%
10 Year Est. Return
+869.55%
AUM
$11.1B
AUM Growth
+$1.23B
(+13%)
Cap. Flow
+$602M
Cap. Flow
% of AUM
5.44%
Top 10 Holdings %
Top 10 Hldgs %
24.18%
Holding
192
New
7
Increased
112
Reduced
59
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$160M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$143M |
| 3 |
Westlake Corp
WLK
|
+$84.8M |
| 4 |
Open Text
OTEX
|
+$68.1M |
| 5 |
Kennametal
KMT
|
+$67.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$107M |
| 2 |
Labcorp
LH
|
+$68M |
| 3 |
State Street
STT
|
+$49.8M |
| 4 |
ZTO Express
ZTO
|
+$44.2M |
| 5 |
Corteva
CTVA
|
+$40.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.42% |
| 2 | Industrials | 19.82% |
| 3 | Financials | 16.32% |
| 4 | Technology | 11.87% |
| 5 | Communication Services | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
United Therapeutics
UTHR
$22.1B
| $692K | 0.01% |
2,409
+585
| +32% | +$175K |
|
177
AB InBev
BUD
$156B
| $618K | 0.01% |
8,987
-4,033
| -31% | -$271K |
|
178
Landstar System
LSTR
$6.13B
| $502K | ﹤0.01% |
3,611
+1,287
| +55% | +$178K |
|
179
Diageo
DEO
$52B
| $433K | ﹤0.01% |
4,290
-42
| -1% | -$4.56K |
|
180
Coca-Cola Femsa
KOF
$23.1B
| $320K | ﹤0.01% |
3,304
-71
| -2% | -$6.73K |
|
181
Gran Tierra Energy
GTE
$333M
| $305K | ﹤0.01% |
63,869
| – | – |
|
182
Barclays
BCS
$94.2B
| – | – |
-74,892
| Closed | -$1.15M |
|
183
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-72,014
| Closed | -$38.4M |
|
184
Crawford & Co Class A
CRD.A
$641M
| – | – |
-209,400
| Closed | -$2.39M |
|
185
Cisco
CSCO
$486B
| – | – |
-406,071
| Closed | -$25.1M |
|
186
General Dynamics
GD
$106B
| – | – |
-52,376
| Closed | -$14.3M |
|
187
iShares Core MSCI Total International Stock ETF
IXUS
$60.7B
| – | – |
-17,906
| Closed | -$1.25M |
|
188
Northwest Natural Holdings
NWN
$2.12B
| – | – |
-56,215
| Closed | -$2.4M |
|
|
SKX
189
DELISTED
Skechers
SKX
| – | – |
-15,653
| Closed | -$889K |
|
190
Sensient Technologies
SXT
$5.61B
| – | – |
-13,935
| Closed | -$1.04M |
|
191
Weis Markets
WMK
$1.77B
| – | – |
-13,511
| Closed | -$1.04M |
|
|
EQC
192
DELISTED
Equity Commonwealth
EQC
| – | – |
-212,045
| Closed | -$341K |
|
Similar funds
FGP
CM
SSA
IFP
TI
SAM
WHG
PSCM
Brandes Investment Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Brandes Investment Partners held 192 positions worth $11.1B, up 13% from $9.83B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Brandes Investment Partners deployed $602M of net new capital in Q2 2025, opening 7 new positions and adding to 112 existing holdings. Its largest new stake was Becton Dickinson: 871,110 shares worth $150M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was McKesson, an estimated $107M trimmed.
- Brandes Investment Partners's largest Q2 2025 buy was Becton Dickinson: 871,110 shares worth $150M.
- Brandes Investment Partners added most to Vanguard Morningstar Value ETF in Q2 2025, an estimated $143M increase.
- Brandes Investment Partners's biggest Q2 2025 reduction was McKesson, cutting an estimated $107M.
- Brandes Investment Partners fully exited Berkshire Hathaway Class B in Q2 2025, selling an estimated $38.4M.
- Brandes Investment Partners's ten largest holdings make up 24% of its $11.1B portfolio in Q2 2025.
- Brandes Investment Partners opened 7 new positions and closed 11 in Q2 2025.
- Brandes Investment Partners's portfolio value rose 13% quarter-over-quarter to $11.1B.
Based on Brandes Investment Partners's 13F filing for Q2 2025, filed 13 Aug 2025.